One More Wrinkle in Battle for Botox Firm Allergan

Allergan approached Salix Pharmaceuticals and at least one other company about a potential acquisition, as the Botox maker seeks to fend off a $53 billion hostile takeover from Valeant Pharmaceuticals.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: PAID Source Type: news